Hayley J. Sharpe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hayley J. Sharpe has a total of 291 co-authors. Here are the top co-authors by number of shared publications:
- Alan Carruthers
Cancer Research Horizons, Cambridge, United Kingdom
9 shared publications - Alice Price
Cancer Research Horizons, Cambridge, United Kingdom
9 shared publications - Amy Fraser
Cancer Research Horizons, Cambridge, United Kingdom
9 shared publications - Andrea F. Lopez-Clavijo
Babraham Institute
9 shared publications - Bebiana C. Sousa
The Babraham Institute, Cambridge, United Kingdom
9 shared publications - Diane Taylor
Babraham Institute, Babraham Research Campus, CB22 3AT Cambridge, UK
9 shared publications
Latest Publications
- Open Access
PTPRF is a stress-responsive cytoskeletal checkpoint that coordinates metabolic adaptation in hepatocytes and β cells
Cytoskeletal remodeling is essential for adaptation to nutrient availability, yet how cells coordinate actin dynamics with glucose homeostasis in metabolic organs remains unclear. Here, we identify a pathway linking metabolic stress to actin reorganization in hepatocytes and pancreatic β cells. This mechanism involves transcriptional repression of the receptor protein tyrosine phosphatase PTPRF by spliced XBP1, a key unfolded protein response factor. In hepatocytes, PTPRF loss under dietary stress enhances insulin signaling, increases mitochondrial respiration and reduces steatosis. Proteomic analyses show that PTPRF interacts with regulators of actin polymerization and cell junctions, and its deletion promotes actin filament organization, shifting metabolism toward oxidative pathways. In β cells, PTPRF deficiency similarly enhances actin polymerization and augments glucose-stimulated insulin secretion in obesity. Collectively, these findings place PTPRF as a nutrient-responsive regulator of cytoskeletal remodeling that coordinates hepatic metabolism and β-cell function, highlighting its potential as a therapeutic target for improving systemic glucose control. Highlights: Actin cytoskeletal organization links cellular structure to metabolism through PTPRF PTPRF loss sustains insulin signaling and oxidative metabolism in hepatocytes PTPRF restrains actin-dependent insulin granule secretion in β cells Cytoskeletal plasticity promotes metabolic adaptation to chronic nutrient excess
Open AccessPTPRF is a stress-responsive cytoskeletal checkpoint that coordinates metabolic adaptation in hepatocytes and β cells
Cytoskeletal remodeling is essential for adaptation to nutrient availability, yet how cells coordinate actin dynamics with glucose homeostasis in metabolic organs remains unclear. Here, we identify a pathway linking metabolic stress to actin reorganization in hepatocytes and pancreatic β cells. This mechanism involves transcriptional repression of the receptor protein tyrosine phosphatase PTPRF by spliced XBP1, a key unfolded protein response factor. In hepatocytes, PTPRF loss under dietary stress enhances insulin signaling, increases mitochondrial respiration and reduces steatosis. Proteomic analyses show that PTPRF interacts with regulators of actin polymerization and cell junctions, and its deletion promotes actin filament organization, shifting metabolism toward oxidative pathways. In β cells, PTPRF deficiency similarly enhances actin polymerization and augments glucose-stimulated insulin secretion in obesity. Collectively, these findings place PTPRF as a nutrient-responsive regulator of cytoskeletal remodeling that coordinates hepatic metabolism and β-cell function, highlighting its potential as a therapeutic target for improving systemic glucose control. Highlights: Actin cytoskeletal organization links cellular structure to metabolism through PTPRF PTPRF loss sustains insulin signaling and oxidative metabolism in hepatocytes PTPRF restrains actin-dependent insulin granule secretion in β cells Cytoskeletal plasticity promotes metabolic adaptation to chronic nutrient excess
- Open Access
Mapping subcellular H 2 O 2 dynamics reveals tissue specific redox patterns in Drosophila
Redox signalling regulates development, tissue homeostasis, and organismal health. Hydrogen peroxide (H 2 O 2 ) is a major signalling form of reactive oxygen species (ROS) that modulates protein activity through oxidation of redox-sensitive cysteines that is reversed by cellular reducing systems. Since H 2 O 2 production, scavenging and reduction are spatially restricted, signalling specificity is strongly influenced by subcellular localisation. However, subcellular H 2 O 2 dynamics in animal tissues remain poorly understood. To address this, we generated and validated Drosophila melanogaster lines expressing the ultrasensitive, ultrafast ratiometric H 2 O 2 biosensor HyPer7 targeted to mitochondria, nucleus, cytosol, or plasma membrane. With its highly conserved metabolic and signalling pathways, tractable lifespan, and powerful genetic toolkit, Drosophila is an ideal model for studying redox biology. These new “FlyPer” lines enable tissue-specific HyPer7 expression and high-resolution measurement of subcellular, in vivo H 2 O 2 dynamics throughout the lifespan. Using FlyPer, we detected compartment-specific H 2 O 2 dynamics during oxidative stress, ageing, wing disc development and embryogenesis, uncovering unexpected patterns of spatially and temporally regulated oxidation throughout the organism. Together, these findings establish FlyPer as a valuable toolkit for in vivo redox biology and suggest that compartmentalised redox dynamics are a fundamental yet still poorly understood layer of developmental programming. Highlights: FlyPer reports in vivo H 2 O 2 dynamics across tissues and subcellular compartments from embryo to adult Redox states are differentially regulated across subcellular compartments during embryonic development Specific embryonic cell types display distinct developmental subcellular H 2 O 2 dynamics Redox gradients mirror anatomical features and morphogen patterns
Open AccessMapping subcellular H 2 O 2 dynamics reveals tissue specific redox patterns in Drosophila
Redox signalling regulates development, tissue homeostasis, and organismal health. Hydrogen peroxide (H 2 O 2 ) is a major signalling form of reactive oxygen species (ROS) that modulates protein activity through oxidation of redox-sensitive cysteines that is reversed by cellular reducing systems. Since H 2 O 2 production, scavenging and reduction are spatially restricted, signalling specificity is strongly influenced by subcellular localisation. However, subcellular H 2 O 2 dynamics in animal tissues remain poorly understood. To address this, we generated and validated Drosophila melanogaster lines expressing the ultrasensitive, ultrafast ratiometric H 2 O 2 biosensor HyPer7 targeted to mitochondria, nucleus, cytosol, or plasma membrane. With its highly conserved metabolic and signalling pathways, tractable lifespan, and powerful genetic toolkit, Drosophila is an ideal model for studying redox biology. These new “FlyPer” lines enable tissue-specific HyPer7 expression and high-resolution measurement of subcellular, in vivo H 2 O 2 dynamics throughout the lifespan. Using FlyPer, we detected compartment-specific H 2 O 2 dynamics during oxidative stress, ageing, wing disc development and embryogenesis, uncovering unexpected patterns of spatially and temporally regulated oxidation throughout the organism. Together, these findings establish FlyPer as a valuable toolkit for in vivo redox biology and suggest that compartmentalised redox dynamics are a fundamental yet still poorly understood layer of developmental programming. Highlights: FlyPer reports in vivo H 2 O 2 dynamics across tissues and subcellular compartments from embryo to adult Redox states are differentially regulated across subcellular compartments during embryonic development Specific embryonic cell types display distinct developmental subcellular H 2 O 2 dynamics Redox gradients mirror anatomical features and morphogen patterns
- Open Access
Loss of PTPRK in hepatocytes reduces steatosis and carcinogen-induced tumour development in obesity
Protein tyrosine phosphatases are crucial regulators of metabolism with specific roles in different tissues. To investigate hepatocyte-specific function of protein tyrosine phosphatase receptor type K (PTPRK), we generated mice carrying floxed Ptprk alleles and crossed them with Alb-Cre mice ( Ptprk ΔHep mice). Under chow feeding, Ptprk ΔHep mice were largely comparable to littermate controls. In contrast, Ptprk ΔHep mice fed a high-fat, high-fructose, high-cholesterol diet exhibited reduced steatosis, lower hepatic PPARγ, and blunted hepatocyte hypertrophy, accompanied by improved systemic insulin sensitivity, as assessed by hyperinsulinemic-euglycemic clamps. We identified PTPRK-interacting proteins enriched for metabolic functions associated with glycolysis and lipid biosynthesis using pull downs from primary hepatocyte lysates. In line with these findings, Ptprk ΔHep mice developed fewer tumours than controls in an obesity and carcinogen-induced hepatocellular carcinoma (HCC) model. Our data show that under nutrient excess PTPRK is functionally engaged in hepatocytes to support PPARγ-linked steatotic growth, insulin resistance, and tumour initiation, highlighting PTPRK as a potential therapeutic target in MASLD-associated HCC.
Open AccessLoss of PTPRK in hepatocytes reduces steatosis and carcinogen-induced tumour development in obesity
Protein tyrosine phosphatases are crucial regulators of metabolism with specific roles in different tissues. To investigate hepatocyte-specific function of protein tyrosine phosphatase receptor type K (PTPRK), we generated mice carrying floxed Ptprk alleles and crossed them with Alb-Cre mice ( Ptprk ΔHep mice). Under chow feeding, Ptprk ΔHep mice were largely comparable to littermate controls. In contrast, Ptprk ΔHep mice fed a high-fat, high-fructose, high-cholesterol diet exhibited reduced steatosis, lower hepatic PPARγ, and blunted hepatocyte hypertrophy, accompanied by improved systemic insulin sensitivity, as assessed by hyperinsulinemic-euglycemic clamps. We identified PTPRK-interacting proteins enriched for metabolic functions associated with glycolysis and lipid biosynthesis using pull downs from primary hepatocyte lysates. In line with these findings, Ptprk ΔHep mice developed fewer tumours than controls in an obesity and carcinogen-induced hepatocellular carcinoma (HCC) model. Our data show that under nutrient excess PTPRK is functionally engaged in hepatocytes to support PPARγ-linked steatotic growth, insulin resistance, and tumour initiation, highlighting PTPRK as a potential therapeutic target in MASLD-associated HCC.
- Top Cited PapersOpen Access
- 20 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 19 (921) , eady9437
Pervanadate-induced oxidation relieves autoinhibition of the protein tyrosine kinase SRC
Dynamic regulation of protein tyrosine phosphorylation (pTyr) by kinases and phosphatases enables cells to sense and respond to environmental changes. The widely used chemical pervanadate induces the accumulation of pTyr in mammalian cell lines. This effect is primarily attributed to its inhibition of protein tyrosine phosphatases (PTPs), leading to the assertion that PTPs are master gatekeepers of intracellular pTyr homeostasis. Here, we used several approaches to reveal that pervanadate disrupted cellular redox homeostasis and directly activated tyrosine kinases of the SRC family through the oxidation of specific cysteine residues. Mass spectrometry and biophysical approaches showed that pervanadate-induced oxidation of cysteine-188 and cysteine-280 activated SRC by disrupting autoinhibitory intramolecular interactions between the catalytic domain and the SH2/SH3 domains and by impairing SH2 domain binding to phosphopeptides, including the regulatory carboxyl-terminal tail phosphotyrosine-530. Redox-sensitive cysteine residues were essential for SRC to promote the overgrowth of mouse fibroblasts. Our findings call for a reevaluation of pervanadate-based experiments and demonstrate that SRC cysteines control its oncogenic properties.
- 20 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 19 (921) , eady9437
Top Cited PapersOpen AccessPervanadate-induced oxidation relieves autoinhibition of the protein tyrosine kinase SRC
Dynamic regulation of protein tyrosine phosphorylation (pTyr) by kinases and phosphatases enables cells to sense and respond to environmental changes. The widely used chemical pervanadate induces the accumulation of pTyr in mammalian cell lines. This effect is primarily attributed to its inhibition of protein tyrosine phosphatases (PTPs), leading to the assertion that PTPs are master gatekeepers of intracellular pTyr homeostasis. Here, we used several approaches to reveal that pervanadate disrupted cellular redox homeostasis and directly activated tyrosine kinases of the SRC family through the oxidation of specific cysteine residues. Mass spectrometry and biophysical approaches showed that pervanadate-induced oxidation of cysteine-188 and cysteine-280 activated SRC by disrupting autoinhibitory intramolecular interactions between the catalytic domain and the SH2/SH3 domains and by impairing SH2 domain binding to phosphopeptides, including the regulatory carboxyl-terminal tail phosphotyrosine-530. Redox-sensitive cysteine residues were essential for SRC to promote the overgrowth of mouse fibroblasts. Our findings call for a reevaluation of pervanadate-based experiments and demonstrate that SRC cysteines control its oncogenic properties.
- Open Access
Pervanadate-induced oxidation relieves autoinhibition of SRC protein tyrosine kinase
Dynamic regulation of protein tyrosine phosphorylation (pTyr) by phosphatases (PTPs) and kinases enables cells to sense and respond to environmental changes. The widely used chemical probe Pervanadate (PV) induces accumulation of high levels of pTyr in cells, an effect primarily attributed to its properties as a PTP inhibitor. This led to the assertion that PTPs are the master gatekeeper of intracellular pTyr homeostasis. Here, we use diverse approaches to reveal that PV disrupts cellular redox homeostasis and directly activates SRC family tyrosine kinases via oxidation of specific cysteine residues. Using mass spectrometry and biophysical approaches, we show that oxidation activates SRC by disrupting autoinhibition and altering phosphopeptide binding by its SH2 domain. We further establish that redox-sensitive cysteine residues are essential for SRC to promote cellular overgrowth. Our findings call for a re-evaluation of PV-based experiments and provide compelling evidence that oxidation is a crucial mechanism in controlling the oncogenic properties of SRC.
Open AccessPervanadate-induced oxidation relieves autoinhibition of SRC protein tyrosine kinase
Dynamic regulation of protein tyrosine phosphorylation (pTyr) by phosphatases (PTPs) and kinases enables cells to sense and respond to environmental changes. The widely used chemical probe Pervanadate (PV) induces accumulation of high levels of pTyr in cells, an effect primarily attributed to its properties as a PTP inhibitor. This led to the assertion that PTPs are the master gatekeeper of intracellular pTyr homeostasis. Here, we use diverse approaches to reveal that PV disrupts cellular redox homeostasis and directly activates SRC family tyrosine kinases via oxidation of specific cysteine residues. Using mass spectrometry and biophysical approaches, we show that oxidation activates SRC by disrupting autoinhibition and altering phosphopeptide binding by its SH2 domain. We further establish that redox-sensitive cysteine residues are essential for SRC to promote cellular overgrowth. Our findings call for a re-evaluation of PV-based experiments and provide compelling evidence that oxidation is a crucial mechanism in controlling the oncogenic properties of SRC.
- Open Access
- 4 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling
Supplementary Figure S4 shows LPAR expression in PDAC cell lines and ATX-mediated pro-tumorigenic stimulation by 0082T conditioned media.
- 4 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling
Supplementary Figure S4 shows LPAR expression in PDAC cell lines and ATX-mediated pro-tumorigenic stimulation by 0082T conditioned media.
- Open Access
- 4 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling
Supplementary Figure S3 shows ATX antibody validation and ATX detection in cancer and CAF co-cultures.
- 4 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling
Supplementary Figure S3 shows ATX antibody validation and ATX detection in cancer and CAF co-cultures.
- Open Access
- 4 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling
Supplementary Figure S5 shows RNA-seq analysis of 0082T CAFs after treatment with ATX inhibitors.
- 4 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling
Supplementary Figure S5 shows RNA-seq analysis of 0082T CAFs after treatment with ATX inhibitors.
- Open Access
- 4 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling
Supplementary Figure S6 shows LLPs expression in PDAC cancer and CAFs cells.
- 4 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling
Supplementary Figure S6 shows LLPs expression in PDAC cancer and CAFs cells.